{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:09:44Z","timestamp":1789171784878,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1RO1NS097722"],"award-info":[{"award-number":["1RO1NS097722"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Epidemiological data suggests statins could reduce the risk of dementia, and more specifically, Alzheimer\u2019s disease (AD). Pre-clinical data suggests statins reduce the risk of dementia through their pleiotropic effects rather than their cholesterol lowering effects. While AD is a leading cause of dementia, it is frequently found co-morbidly with cerebral small vessel disease and other vascular contributions to cognitive impairment and dementia (VCID), which are another leading cause of dementia. In this study, we determined if atorvastatin ameliorated hyperhomocysteinemia (HHcy)-induced VCID.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Wild-type (C57Bl6\/J) mice were placed on a diet to induce HHcy or a control diet each with or without atorvastatin for 14\u00a0weeks. Mice underwent novel object recognition testing before tissue collection. Plasma total cholesterol and total homocysteine as well as related metabolites were measured. Using qPCR and NanoString technology, we profiled glial cell-associated gene expression changes. Finally, microglial morphology, astrocyte end feet, and microhemorrhages were analyzed using histological methods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Atorvastatin treatment of HHcy in mice led to no changes in total cholesterol but decreases in total homocysteine in plasma. While HHcy decreased expression of many glial genes, atorvastatin rescued these gene changes, which mostly occurred in oligodendrocytes and microglia. Microglia in HHcy mice with atorvastatin were trending towards fewer processes compared to control with atorvastatin, but there were no atorvastatin effects on astrocyte end feet. While atorvastatin treatment was trending towards increasing the area of microhemorrhages in HHcy mice in the frontal cortex, it only slightly (non-significantly) reduced the number of microhemorrhages. Finally, atorvastatin treatment in HHcy mice led to improved cognition on the novel object recognition task.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These data suggest that atorvastatin rescued cognitive changes induced by HHcy most likely through lowering plasma total homocysteine and rescuing gene expression changes rather than impacts on vascular integrity or microglial changes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-023-02883-x","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T16:03:22Z","timestamp":1693584202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Atorvastatin rescues hyperhomocysteinemia-induced cognitive deficits and neuroinflammatory gene changes"],"prefix":"10.1186","volume":"20","author":[{"given":"Erica M.","family":"Weekman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherika N.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin B.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany L.","family":"Sudduth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Fardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodoro","family":"Bottiglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Wilcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"issue":"3","key":"2883_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000503105","volume":"54","author":"TN Poly","year":"2020","unstructured":"Poly TN, Islam MM, Walther BA, Yang HC, Wu CC, Lin MC, et al. Association between use of statin and risk of dementia: a meta-analysis of observational studies. Neuroepidemiology. 2020;54(3):214\u201326.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"2883_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13195-020-00658-7","volume":"12","author":"YW Cheng","year":"2020","unstructured":"Cheng YW, Chiu MJ, Chen YF, Cheng TW, Lai YM, Chen TF. The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12(1):91.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"2883_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/eurjpc\/zwab208","volume":"29","author":"E Olmastroni","year":"2022","unstructured":"Olmastroni E, Molari G, De Beni N, Colpani O, Galimberti F, Gazzotti M, et al. Statin use and risk of dementia or Alzheimer\u2019s disease: a systematic review and meta-analysis of observational studies. Eur J Prev Cardiol. 2022;29(5):804\u201314.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"2883_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12108","volume":"6","author":"G Torrandell-Haro","year":"2020","unstructured":"Torrandell-Haro G, Branigan GL, Vitali F, Geifman N, Zissimopoulos JM, Brinton RD. Statin therapy and risk of Alzheimer\u2019s and age-related neurodegenerative diseases. Alzheimers Dement (N Y). 2020;6(1): e12108.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"2883_CR5","doi-asserted-by":"publisher","first-page":"15280","DOI":"10.1038\/s41598-021-94803-3","volume":"11","author":"SM Jeong","year":"2021","unstructured":"Jeong SM, Shin DW, Yoo TG, Cho MH, Jang W, Lee J, et al. Association between statin use and Alzheimer\u2019s disease with dose response relationship. Sci Rep. 2021;11(1):15280.","journal-title":"Sci Rep"},{"issue":"25","key":"2883_CR6","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1016\/j.jacc.2021.04.075","volume":"77","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Ryan J, Ernst ME, Zoungas S, Tonkin AM, Woods RL, et al. Effect of statin therapy on cognitive decline and incident dementia in older adults. J Am Coll Cardiol. 2021;77(25):3145\u201356.","journal-title":"J Am Coll Cardiol"},{"key":"2883_CR7","volume":"2","author":"B McGuinness","year":"2009","unstructured":"McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2009;2: CD03160.","journal-title":"Cochrane Database Syst Rev"},{"issue":"19 Pt 2","key":"2883_CR8","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/01.wnl.0000288181.00826.63","volume":"70","author":"Z Arvanitakis","year":"2008","unstructured":"Arvanitakis Z, Schneider JA, Wilson RS, Bienias JL, Kelly JF, Evans DA, et al. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology. 2008;70(19 Pt 2):1795\u2013802.","journal-title":"Neurology"},{"issue":"37","key":"2883_CR9","doi-asserted-by":"publisher","first-page":"26832","DOI":"10.1074\/jbc.M702640200","volume":"282","author":"SM Ostrowski","year":"2007","unstructured":"Ostrowski SM, Wilkinson BL, Golde TE, Landreth G. Statins reduce amyloid-beta production through inhibition of protein isoprenylation. J Biol Chem. 2007;282(37):26832\u201344.","journal-title":"J Biol Chem"},{"issue":"1","key":"2883_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-017-0934-2","volume":"14","author":"X Xu","year":"2017","unstructured":"Xu X, Gao W, Cheng S, Yin D, Li F, Wu Y, et al. Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury. J Neuroinflamm. 2017;14(1):167.","journal-title":"J Neuroinflamm"},{"issue":"3","key":"2883_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.phrs.2010.12.007","volume":"63","author":"E Barone","year":"2011","unstructured":"Barone E, Cenini G, Di Domenico F, Martin S, Sultana R, Mancuso C, et al. Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action. Pharmacol Res. 2011;63(3):172\u201380.","journal-title":"Pharmacol Res"},{"issue":"6","key":"2883_CR12","doi-asserted-by":"publisher","first-page":"1981S","DOI":"10.3945\/ajcn.2009.27230C","volume":"89","author":"L Hoey","year":"2009","unstructured":"Hoey L, Strain JJ, McNulty H. Studies of biomarker responses to intervention with vitamin B-12: a systematic review of randomized controlled trials. Am J Clin Nutr. 2009;89(6):1981S-S1996.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"2883_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/ajcn\/58.4.468","volume":"58","author":"E Joosten","year":"1993","unstructured":"Joosten E, van den Berg A, Riezler R, Naurath HJ, Lindenbaum J, Stabler SP, et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr. 1993;58(4):468\u201376.","journal-title":"Am J Clin Nutr"},{"key":"2883_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2318-13-13","volume":"13","author":"IK Kjeldby","year":"2013","unstructured":"Kjeldby IK, Fosnes GS, Ligaarden SC, Farup PG. Vitamin B6 deficiency and diseases in elderly people\u2013a study in nursing homes. BMC Geriatr. 2013;13:13.","journal-title":"BMC Geriatr"},{"issue":"1","key":"2883_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12974-019-1685-z","volume":"16","author":"EM Weekman","year":"2019","unstructured":"Weekman EM, Sudduth TL, Price BR, Woolums AE, Hawthorne D, Seaks CE, et al. Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events. J Neuroinflamm. 2019;16(1):284.","journal-title":"J Neuroinflamm"},{"key":"2883_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuroscience.2016.11.024","volume":"341","author":"TL Sudduth","year":"2017","unstructured":"Sudduth TL, Weekman EM, Price BR, Gooch JL, Woolums A, Norris CM, et al. Time-course of glial changes in the hyperhomocysteinemia model of vascular cognitive impairment and dementia (VCID). Neuroscience. 2017;341:42\u201351.","journal-title":"Neuroscience"},{"issue":"12","key":"2883_CR17","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.3390\/ijms22126468","volume":"22","author":"H Lastuvkova","year":"2021","unstructured":"Lastuvkova H, Faradonbeh FA, Schreiberova J, Hroch M, Mokry J, Faistova H, et al. Atorvastatin modulates bile acid homeostasis in mice with diet-induced nonalcoholic steatohepatitis. Int J Mol Sci. 2021;22(12):6468.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2883_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mc.21916","volume":"52","author":"J Liao","year":"2013","unstructured":"Liao J, Chung YT, Yang AL, Zhang M, Li H, Zhang W, et al. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice. Mol Carcinog. 2013;52(9):739\u201350.","journal-title":"Mol Carcinog"},{"issue":"3","key":"2883_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659\u201361.","journal-title":"FASEB J"},{"issue":"5","key":"2883_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/0271678X211069006","volume":"42","author":"CE Seaks","year":"2022","unstructured":"Seaks CE, Weekman EM, Sudduth TL, Xie K, Wasek B, Fardo DW, et al. Apolipoprotein E epsilon4\/4 genotype limits response to dietary induction of hyperhomocysteinemia and resulting inflammatory signaling. J Cerebr Blood Flow Metab. 2022;42(5):771\u201387.","journal-title":"J Cerebr Blood Flow Metab"},{"key":"2883_CR21","doi-asserted-by":"crossref","unstructured":"Alzheimer's disease facts and figures. Alzheimer's Dementia. 2022;18(4):700\u201389","DOI":"10.1002\/alz.12638"},{"issue":"9","key":"2883_CR22","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/S0022-2275(20)37904-9","volume":"24","author":"MC Camus","year":"1983","unstructured":"Camus MC, Chapman MJ, Forgez P, Laplaud PM. Distribution and characterization of the serum lipoproteins and apoproteins in the mouse. Mus musculus J Lipid Res. 1983;24(9):1210\u201328.","journal-title":"Mus musculus J Lipid Res"},{"issue":"2","key":"2883_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.atherosclerosis.2010.11.008","volume":"214","author":"I Bot","year":"2011","unstructured":"Bot I, Jukema JW, Lankhuizen IM, van Berkel TJ, Biessen EA. Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels. Atherosclerosis. 2011;214(2):295\u2013300.","journal-title":"Atherosclerosis"},{"issue":"7","key":"2883_CR24","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1002\/art.23605","volume":"58","author":"KL Graham","year":"2008","unstructured":"Graham KL, Lee LY, Higgins JP, Steinman L, Utz PJ, Ho PP. Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus. Arthr Rheum. 2008;58(7):2098\u2013104.","journal-title":"Arthr Rheum."},{"issue":"5","key":"2883_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4093\/dmj.2016.40.5.376","volume":"40","author":"HS Park","year":"2016","unstructured":"Park HS, Jang JE, Ko MS, Woo SH, Kim BJ, Kim HS, et al. Statins increase mitochondrial and peroxisomal fatty acid oxidation in the liver and prevent non-alcoholic steatohepatitis in mice. Diabetes Metab J. 2016;40(5):376\u201385.","journal-title":"Diabetes Metab J"},{"issue":"6","key":"2883_CR26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","volume":"99","author":"D Liao","year":"2006","unstructured":"Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ Res. 2006;99(6):598\u2013606.","journal-title":"Circ Res"},{"issue":"10","key":"2883_CR27","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1172\/JCI11596","volume":"107","author":"GH Werstuck","year":"2001","unstructured":"Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Investig. 2001;107(10):1263\u201373.","journal-title":"J Clin Investig"},{"issue":"1","key":"2883_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12944-017-0441-6","volume":"16","author":"M Momin","year":"2017","unstructured":"Momin M, Jia J, Fan F, Li J, Dou J, Chen D, et al. Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population. Lipids Health Dis. 2017;16(1):54.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2883_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/lipd.12279","volume":"56","author":"X Niu","year":"2021","unstructured":"Niu X, Chen J, Wang J, Li J, Zeng D, Wang S, et al. A cross-sectional study on the relationship between homocysteine and lipid profiles among Chinese population from Hunan. Lipids. 2021;56(1):93\u2013100.","journal-title":"Lipids"},{"issue":"2","key":"2883_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.fertnstert.2008.06.006","volume":"92","author":"C Kaya","year":"2009","unstructured":"Kaya C, Cengiz SD, Berker B, Demirtas S, Cesur M, Erdogan G. Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study. Fertil Steril. 2009;92(2):635\u201342.","journal-title":"Fertil Steril"},{"issue":"1","key":"2883_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9150(00)00735-8","volume":"155","author":"D Luftjohann","year":"2001","unstructured":"Luftjohann D, Sigit JI, Locatelli S, von Bergmann K, Schmidt HH. High-dose simvastin (80 mg\/day) decreases plasma concentrations of total homocyst(e)ine in patients with hypercholesteromia. Atherosclerosis. 2001;155(1):265\u20136.","journal-title":"Atherosclerosis"},{"issue":"4","key":"2883_CR32","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1111\/1755-5922.12002","volume":"31","author":"S Jiang","year":"2013","unstructured":"Jiang S, Chen Q, Venners SA, Zhong G, Hsu YH, Xing H, et al. Effect of simvastatin on plasma homocysteine levels and its modification by MTHFR C677T polymorphism in Chinese patients with primary hyperlipidemia. Cardiovasc Ther. 2013;31(4):e27-33.","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"2883_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1139\/o79-007","volume":"57","author":"DR Hoffman","year":"1979","unstructured":"Hoffman DR, Cornatzer WE, Duerre JA. Relationship between tissue levels of S-adenosylmethionine, S-adenylhomocysteine, and transmethylation reactions. Can J Biochem. 1979;57(1):56\u201365.","journal-title":"Can J Biochem"},{"issue":"6","key":"2883_CR34","doi-asserted-by":"publisher","first-page":"175909141774229","DOI":"10.1177\/1759091417742296","volume":"9","author":"EM Weekman","year":"2017","unstructured":"Weekman EM, Woolums AE, Sudduth TL, Wilcock DM. Hyperhomocysteinemia-induced gene expression changes in the cell types of the brain. ASN Neuro. 2017;9(6):1759091417742296.","journal-title":"ASN Neuro"},{"issue":"1","key":"2883_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12368","volume":"8","author":"EM Weekman","year":"2022","unstructured":"Weekman EM, Winder Z, Rogers CB, Abner EL, Sudduth TL, Patel E, et al. Genetic expression changes and pathologic findings associated with hyperhomocysteinemia in human autopsy brain tissue. Alzheimers Dement (N Y). 2022;8(1): e12368.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"11","key":"2883_CR36","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41440-022-00999-w","volume":"45","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Cai X, Liu Y, Li N. Dose-response association between plasma homocysteine and white matter lesions in patients with hypertension: a case-control study. Hypertens Res. 2022;45(11):1794\u2013801.","journal-title":"Hypertens Res"},{"issue":"6","key":"2883_CR37","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/01.STR.0000165923.02318.22","volume":"36","author":"CB Wright","year":"2005","unstructured":"Wright CB, Paik MC, Brown TR, Stabler SP, Allen RH, Sacco RL, et al. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke. 2005;36(6):1207\u201311.","journal-title":"Stroke"},{"issue":"5","key":"2883_CR38","first-page":"708","volume":"33","author":"TL Sudduth","year":"2013","unstructured":"Sudduth TL, Powell DK, Smith CD, Greenstein A, Wilcock DM. Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation. J Cereb. 2013;33(5):708\u201315.","journal-title":"J Cereb"},{"issue":"7","key":"2883_CR39","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/aps.2012.59","volume":"33","author":"Y Jin","year":"2012","unstructured":"Jin Y, Sui HJ, Dong Y, Ding Q, Qu WH, Yu SX, et al. Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt\/mTOR and Akt\/GSK-3beta signaling pathways. Acta Pharmacol Sin. 2012;33(7):861\u201372.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2883_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12890-020-01307-3","volume":"20","author":"J Guo","year":"2020","unstructured":"Guo J, Li M, Yang Y, Zhang L, Zhang LW, Sun QY. Pretreatment with atorvastatin ameliorates cobra venom factor-induced acute lung inflammation in mice. BMC Pulm Med. 2020;20(1):263.","journal-title":"BMC Pulm Med"},{"issue":"1\u20132","key":"2883_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.0300-9475.2004.01439.x","volume":"60","author":"KT Lappegard","year":"2004","unstructured":"Lappegard KT, Hvassing T, Mollnes TE. Statin drugs do not affect serum complement activation in vitro. Scand J Immunol. 2004;60(1\u20132):178\u201383.","journal-title":"Scand J Immunol"},{"key":"2883_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117224","volume":"420","author":"AH Katsanos","year":"2021","unstructured":"Katsanos AH, Lioutas VA, Charidimou A, Catanese L, Ng KKH, Perera K, et al. Statin treatment and cerebral microbleeds: a systematic review and meta-analysis. J Neurol Sci. 2021;420: 117224.","journal-title":"J Neurol Sci"},{"issue":"10","key":"2883_CR43","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1161\/STROKEAHA.112.657486","volume":"43","author":"DC Haussen","year":"2012","unstructured":"Haussen DC, Henninger N, Kumar S, Selim M. Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage. Stroke. 2012;43(10):2677\u201381.","journal-title":"Stroke"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02883-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02883-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02883-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T19:14:04Z","timestamp":1700421244000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02883-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2883"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02883-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"21 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures conformed to the National Institutes of Health Guide for the Care and Use of Animals in Research and were approved by the University of Kentucky Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}